HG induces a decline in the MFN2‐PERK interaction, suggesting that the MFN2‐PERK signaling pathway may serve as a novel therapeutic target to prevent podocyte injury in DKD (Cao et al., 2021). Here, MFN2 is linked to diabetic kidney disease.